Abiopharma

🔍 Virnich Daniel (Executive)

Company: Oncology Institute, Inc. (TOI)

Report Date: 2026-03-27

Detailed Transactions and Holdings:

• Sold 670,608 shares of Common Stock (Direct)
  Date: 2026-03-27 | Code: A | equity_swap_involved: 0 | shares_owned_after: 2,458,758.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 98,534 shares of Common Stock at $3.07 per share (Direct)
  Date: 2026-03-27 | Code: J | equity_swap_involved: 0 | shares_owned_after: 2,360,224.00 | transaction_form_type: 4 | Footnotes: F2

Footnotes:

• F1: Represents RSU awards with 1/4 of the RSUs vesting on the first anniversary of the Vesting Commencement Date, with the remaining RSUs vesting in three equal annual installments beginning on the first anniversary of the Vesting Commencement Date, with all RSUs becoming vested on the fourth anniversary of the Vesting Commencement Date, subject to continued service with the Company through such vesting dates.
• F2: The Issuer executed the sale to cover the tax liabilities arising from the vesting of an RSU award on March 31, 2026.